References
- Anderson KL, Burckhardt CS. Conceptualization and measurement of quality of life as an outcome variable for health care intervention and research. J Adv Nurs. 1999;29:298–306. doi:https://doi.org/10.1046/j.1365-2648.1999.00889.x
- Andrykowski MA, Lykins E, Floyd A. Psychological health in cancer survivors. Semin Oncol Nurs. 2008;24:193–201. doi:https://doi.org/10.1016/j.soncn.2008.05.007
- Carrera PM, Kantarjian HM, Blinder VS. The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J Clin. 2018;68:153–165. doi:https://doi.org/10.3322/caac.21443
- Altice CK, Banegas MP, Tucker-Seeley RD, et al. Financial hardships experienced by cancer survivors: a systematic review. J Natl Cancer Inst. 2016;109:djw205. doi:https://doi.org/10.1093/jnci/djw205
- Choi SH, Terrell JE, Fowler KE, et al. Socioeconomic and other demographic disparities predicting survival among head and neck cancer patients. PLoS One. 2016;11:e0149886. doi:https://doi.org/10.1371/journal.pone.0149886
- Zafar SY. Financial toxicity of cancer care: it’s time to intervene. J Natl Cancer Inst. 2015;108:djv370.
- Arozullah AM, Calhoun EA, Wolf M, et al. The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. 2004;2:271–278.
- Davidoff AJ, Hill SC, Bernard D, et al. The affordable care act and expanded insurance eligibility among nonelderly adult cancer survivors. J Natl Cancer Inst. 2015;107:djv181. doi:https://doi.org/10.1093/jnci/djv181
- Souza JA, Yap BJ, Hlubocky FJ, et al. The development of a financial toxicity patient‐reported outcome in cancer: the COST measure. Cancer. 2014;120:3245–3253. doi:https://doi.org/10.1002/cncr.28814
- De Souza JA, Yap BJ, Wroblewski K, et al. Measuring financial toxicity as a clinically relevant patient‐reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer. 2017;123:476–484. doi:https://doi.org/10.1002/cncr.30369
- Chino F, Peppercorn JM, Rushing C, et al. Out-of-pocket costs, financial distress, and underinsurance in cancer care. JAMA Oncol. 2017;3:1582–1584. doi:https://doi.org/10.1001/jamaoncol.2017.2148
- Ramsey SD, Bansal A, Fedorenko CR, et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. 2016;34:980. doi:https://doi.org/10.1200/JCO.2015.64.6620
- Singh GK, Jemal A. Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950-2014: over six decades of changing patterns and widening inequalities. J Environ Public Health. 2017;1–19.
- Zafar SY, McNeil RB, Thomas CM, et al. Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study. J Oncol Pract. 2014;11:145–150.
- Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208. doi:https://doi.org/10.1016/j.jbi.2019.103208
- Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42:377–381. doi:https://doi.org/10.1016/j.jbi.2008.08.010
- Cella D, Tulsky D, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–579. doi:https://doi.org/10.1200/JCO.1993.11.3.570
- Cella D, Riley W, Stone A, et al. The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63:1179–1194. doi:https://doi.org/10.1016/j.jclinepi.2010.04.011
- Cook KF, Jensen SE, Schalet BD, et al. PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions. J Clin Epidemiol. 2016;73:89–102. doi:https://doi.org/10.1016/j.jclinepi.2015.08.038
- Schalet BD, Pilkonis PA, Yu L, et al. Clinical validity of PROMIS(®) depression, anxiety, and anger across diverse clinical samples. J Clin Epidemiol. 2016;73:119–127. doi:https://doi.org/10.1016/j.jclinepi.2015.08.036
- Amtmann D, Kim J, Chung H, et al. Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis. Rehabil Psychol. 2014;59:220–229. doi:https://doi.org/10.1037/a0035919
- Revicki DA, Chen W-H, Harnam N, et al. Development and psychometric analysis of the PROMIS pain behavior item bank. Pain. 2009;146:158–169. doi:https://doi.org/10.1016/j.pain.2009.07.029
- Cessna JM, Jim HS, Sutton SK, et al. Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patients. J Psychosom Res. 2016;81:9–13. doi:https://doi.org/10.1016/j.jpsychores.2015.12.002
- Jensen RE, Potosky AL, Reeve BB, et al. Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients. Qual Life Res. 2015;24:2333–2344. doi:https://doi.org/10.1007/s11136-015-0992-9
- Webster K, Cella D, Yost K. The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes. 2003;1:79.
- NIH. NIH Toolbox. NIH; 2019. https://www.healthmeasures.net/explore-measurement-systems/nih-toolbox
- Gonzalez‐Saenz de Tejada M, Bilbao A, Baré M, et al. Association between social support, functional status, and change in health‐related quality of life and changes in anxiety and depression in colorectal cancer patients. Psychooncology. 2017;26:1263–1269. doi:https://doi.org/10.1002/pon.4303
- Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013;18:381–390. doi:https://doi.org/10.1634/theoncologist.2012-0279
- Fenn KM, Evans SB, McCorkle R, et al. Impact of financial burden of cancer on survivors' quality of life. J Oncol Pract. 2014;10:332–338. doi:https://doi.org/10.1200/JOP.2013.001322
- Ting CY, Teh GC, Yu KL, et al. Financial toxicity and its associations with health-related quality of life among urologic cancer patients in an upper middle-income country. Support Care Cancer. 2020;28:1703–1715.
- Perrone F, Jommi C, Di Maio M, et al. The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy. Ann Oncol. 2016;27(12):2224–2229. doi:https://doi.org/10.1093/annonc/mdw433
- Hastert TA, Kyko JM, Reed AR, et al. Financial hardship and quality of life among African American and white cancer survivors: the role of limiting care due to cost. Cancer Epidemiol Biomarkers Prev. 2019;28(7):1202–1211.
- Lathan CS, Cronin A, Tucker-Seeley R, et al. Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. J Clin Oncol. 2016;34:1732. doi:https://doi.org/10.1200/JCO.2015.63.2232
- Van Den Beuken-Van MH, Hochstenbach LM, Joosten EA, et al. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51:1070–1090.e9. doi:https://doi.org/10.1016/j.jpainsymman.2015.12.340
- Rodriguez C, Ji M, Wang H-L, et al. Cancer pain and quality of life. J Hosp Palliat Nurs. 2019;21:116–123. doi:https://doi.org/10.1097/NJH.0000000000000507
- Im E-O, Lee SH, Liu Y, et al. A national online forum on ethnic differences in cancer pain experience. Nurs Res. 2009;58:86.
- Ham O-K, Chee W, Im E-O. The influence of social structure on cancer pain and quality of life. West J Nurs Res. 2017;39:1547–1566. doi:https://doi.org/10.1177/0193945916672663
- Zaza C, Baine N. Cancer pain and psychosocial factors: a critical review of the literature. J Pain Symptom Manage. 2002;24:526–542. doi:https://doi.org/10.1016/s0885-3924(02)00497-9
- Ng CG, Boks MP, Zainal NZ, et al. The prevalence and pharmacotherapy of depression in cancer patients. J Affect Disord. 2011;131:1–7. doi:https://doi.org/10.1016/j.jad.2010.07.034
- Ciaramella A, Poli P. Assessment of depression among cancer patients: the role of pain, cancer type and treatment. Psychooncology. 2001;10:156–165.
- Hotopf M, Chidgey J, Addington-Hall J, et al. Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med. 2002;16:81–97. doi:https://doi.org/10.1191/02169216302pm507oa
- Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160–174. doi:https://doi.org/10.1016/S1470-2045(11)70002-X
- Akechi T, Okamura H, Nakano T, et al. Gender differences in factors associated with suicidal ideation in major depression among cancer patients. Psychooncology. 2010;19:384–389. doi:https://doi.org/10.1002/pon.1587
- Sauer C, Weis J, Faller H, et al. Impact of social support on psychosocial symptoms and quality of life in cancer patients: results of a multilevel model approach from a longitudinal multicenter study. Acta Oncol. 2019;58(9):1298–1306. doi:https://doi.org/10.1080/0284186X.2019.1631471
- Pinquart M, Duberstein P. Depression and cancer mortality: a meta-analysis. Psychol Med. 2010;40:1797–1810. doi:https://doi.org/10.1017/S0033291709992285
- Breitbart W, Rosenfeld B, Pessin H, et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA. 2000;284:2907–2911. doi:https://doi.org/10.1001/jama.284.22.2907